In this exclusive “Healthcare Unfiltered” podcast episode, I host passionate physicians and explore their alternate passion when they are not taking care of patients or doing research. Namely: MUSIC.
I was featured on the Graft Podcast talking about good medicine, the art of being human, actually caring for patients, and the essence of science and its abuse in current times of COVID. This is what EBMT Trainees had to say about our conversation: With his podcast healthcare unfiltered, his perspective articles in Journal of
Hosts of Beyond the Journal, Jack West & Charu Aggarwal, asked me to come on their podcast to chat about the balance of medical talent between academia & industry, as well as the advantages of different social media platforms for thoughtful discussion. (45:04)
The Health Professional Radio interviewed myself, as well as Dr. Stephen Liu, an oncologist with Medstar Health and an investigator on this study, to discuss the data presentation from the American Society of Clinical Oncology (ASCO 2020) Virtual Scientific Program, Abstract 9544/Poster 310: Characterization of KRAS mutations in non-small cell lung cancer (NSCLC).
Medscape Oncology Insights recently published an interview I conducted with Dr Jeff Sharman, director of research at Willamette Valley Cancer Institute and medical director of hematology research for The US Oncology Network.
As we kicked off 2020, one of the most anticipated events for the industry was the introduction of several more Herceptin, Avastin, and Rituxan competitors in the curative oncology mAb space. After the first three launches which will be completed in March, the U.S. will have finally welcomed a little more than half of the 26 biosimilars currently approved.
Chadi Nabhan, MD MBA of Aptitude Health discusses the potential of biosimilars in the treatment of blood cancer.
Part 2 of 2. Review part 1 here. Dr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments.
Dr. Nabhan has been podcasting for years. His first podcast “Outspoken Oncology” started in February 2019 and won him two communication awards especially with dedicated coverage to COVID-19 when the pandemic started. That podcast retired in the summer of 2020 and Dr. Nabhan currently hosts two podcasts:
Healthcare Unfiltered: unedited and daring podcast tackling all aspects of healthcare hosting thought leaders from all over the world addressing timely and relevant debates that are important to everyone in the healthcare industry
HemOnc Pulse: Started in December 2022 and is dedicated to hematology and only hematology. Dr. Nabhan hosts thought leaders in the field of hematology discussing recent updates, new published research, debates, and asks questions that are essential to clinical care. This podcast is sponsored by Blood Cancers Today and SOHO.
